Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2015-002176-25Phase 2Completed
Phase 2, single-arm trial of botulinum toxin type A in rotator cuff arthropathy (CTA), sponsored by Royal Devon University Healthcare NHS Foundation Trust. Primary endpoint: VAS pain score change over time. Started Feb 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2015-002176-25.